Featured Research

from universities, journals, and other organizations

Ultrasound guided pudendal nerve block: A cadaveric study

Date:
March 6, 2014
Source:
American Academy of Pain Medicine (AAPM)
Summary:
The spread of close to 80% of injectate to surrounding soft tissues following a nerve block to treat chronic pelvic pain suggests a need to reduce the quantity injected, according to a new study.

The spread of close to 80% of injectate to surrounding soft tissues following a nerve block to treat chronic pelvic pain suggests a need to reduce the quantity injected, according to study authors, who presented results in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine.

Though needles were accurately placed during ultrasound-guided pudendal nerve block (PNB) in a cadaver study, results show only 20% of the injectate was found in the interligamentous space, which was the target site. This type of finding has gone largely unexplored in the previous literature, the researchers said.

Lead study author Yuexiang Wang, MD, of the Mayo Clinic's Department of Anesthesiology in Rochester, Minn., said 4-5 mL of injectate is the most commonly used volume in PNB, either guided by fluoroscopy, computed tomography (CT) or ultrasound.

"Although favorable clinical results have been reported by using this amount of injectate, unintended sciatic nerve block is not a rare complication," Dr. Wang said. "Thus, it is unclear as to whether 4 mL, while being effective in blocking the nerve, may be too much volume for the space into which it is being injected."

The investigators searched previous studies and found none addressing the spread pattern of 4 mL injectate under ultrasound guidance, although the spread pattern of a larger amount of injectate (10 mL) was reported (Prat-Pradal et al, Surg Radiol Anat 2009; 31(4):289-93). They decided to study the spread of 4 mL injectate at the level of the ischial spine to better understand what the appropriate volume might be.

For the study, investigators performed PNB bilaterally in 2 cadavers. Guided by ultrasound via a 5 MHz curvilinear transducer, they injected 4 mL of iodine-based contrast into the space between the sacrotuberous ligament and sacrospinous ligament, just medial to the ischial spine.

Using cone-beam CT to assess the spread, investigators observed contrast had spread to the following areas:

• The perirectal fat in 3 injections

• Alcock's canal in 2 injections

• The gluteus maximus and piriformis muscles in 1 injection

No spread to surrounding blood vessels was observed.

Dr. Wang said the effects of the spread outside the interligamentous plane are unpredictable and could be beneficial or detrimental for clinical patients.

"On one hand, the spread of the contrast into the Alcock's canal and the perirectal fat space may cause additional blockage of the inferior rectal nerve, which arises from the pudendal nerve at the beginning of the pudendal canal, then enter the proximal part of the ischiorectal fossa in most cases," Dr. Wang said. "On the other hand, the spread into the gluteus maximus and piriformis muscle may cause an unintended sciatic nerve block which is considered a potential risk for PNB."

Ultrasound PNB has been shown to be effective in treating pudendal neuralgia, which is a common cause of chronic pelvic pain (Rofaeel et al, Reg Anesth Pain Med 2008;33(2):139-45). Using ultrasound to guide the procedure is touted by supporters as advantageous for clearly visualizing each anatomical landmark during treatment, thus increasing accuracy and avoiding the risk of unintended intravascular injection and sciatic nerve block.


Story Source:

The above story is based on materials provided by American Academy of Pain Medicine (AAPM). Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Pain Medicine (AAPM). "Ultrasound guided pudendal nerve block: A cadaveric study." ScienceDaily. ScienceDaily, 6 March 2014. <www.sciencedaily.com/releases/2014/03/140306211036.htm>.
American Academy of Pain Medicine (AAPM). (2014, March 6). Ultrasound guided pudendal nerve block: A cadaveric study. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/03/140306211036.htm
American Academy of Pain Medicine (AAPM). "Ultrasound guided pudendal nerve block: A cadaveric study." ScienceDaily. www.sciencedaily.com/releases/2014/03/140306211036.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins